Important Treatment Considerations for Patients with Relapsed or Refractory Multiple Myeloma
GlaxoSmithKline
September 17, 2020
Join a clinical educator as she provides an in-depth review of a treatment for patients with relapsed or refractory multiple myeloma. This presentation will discuss important prescribing information, clinical data, and address other commonly asked questions.
Session: Important Treatment Considerations for Patients with Relapsed or Refractory Multiple Myeloma
Speaker: Lisa Briggs, OCE